Centrum and Novorapid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Centrum (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e) and Novorapid (insulin aspart recombinant). Common drug interactions include headache among females and metastatic renal cell carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Centrum and Novorapid. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Centrum?

Centrum has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 34,686 Centrum users. Check the latest studies of Centrum.

What is Novorapid?

Novorapid has active ingredients of insulin aspart recombinant. It is often used in type 1 diabetes. eHealthMe is studying from 24,730 Novorapid users. Check the latest studies of Novorapid.

On Jul, 06, 2026

13 people who take Centrum and Novorapid together, and have interactions are studied.

Centrum and Novorapid drug interactions.

What are the common drug interactions of Centrum and Novorapid, by gender? *:

female:

Headache (pain in head)
Hyperkalaemia (damage to or disease of the kidney)
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Renal impairment (severely reduced kidney function)
Vomiting
Fall
Hyperhidrosis (abnormally increased sweating)
Insomnia (sleeplessness)
Memory impairment

male:

Metastatic renal cell carcinoma (spreadable kidney cell tumour)
General physical health deterioration (weak health status)
Hyperkalaemia (damage to or disease of the kidney)
Blood iron decreased
Blood triglycerides increased
Prostate cancer

What are the common drug interactions of Centrum and Novorapid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

30-39:

n/a

40-49:

General physical health deterioration (weak health status)
Hyperkalaemia (damage to or disease of the kidney)

50-59:

n/a

60+:

Metastatic renal cell carcinoma (spreadable kidney cell tumour)
Dehydration (dryness resulting from the removal of water)
Vomiting
Fall
Hyperhidrosis (abnormally increased sweating)
Insomnia (sleeplessness)
Arthralgia (joint pain)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood glucose decreased
Blood iron decreased

What are the existing conditions these people have? *

Type 2 Diabetes: 6 people, 46.15%
Thyroid Diseases: 2 people, 15.38%
Stress And Anxiety: 2 people, 15.38%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
Depression: 2 people, 15.38%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 7.69%
Gastric Disorder (disease of stomach): 1 person, 7.69%
Arrhythmias (irregular heartbeat): 1 person, 7.69%
Blood Disorder: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Centrum and Novorapid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously